DrugPatentWatch Database Preview
Litigation Details for Takeda GMBH v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2015)
Takeda GMBH v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2015)
| Docket | Start Trial | Date Filed | 2015-05-27 |
| Court | District Court, N.D. West Virginia | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
| Jury Demand | None | Referred To | |
| Parties | ASTRAZENECA PHARMACEUTICALS LP; ASTRAZENECA UK LIMITED; MYLAN PHARMACEUTICALS INC.; TAKEDA GMBH | ||
| Patents | 5,712,298; 8,431,154; 8,536,206; 8,604,064; 8,618,142 | ||
| Attorneys | Amy K. Wigmore; Christopher A. Lauderman; Dennis Gregory; Gordon H. Copland; James F. Companion; Mary Procaccio-Flowers; Nancy Zhang; Tracey C. Allen; Tung-On Kong; William J O'Brien; Yolonda G. Lambert | ||
| Firms | Steptoe & Johnson PLLC - Bridgeport; Steptoe & Johnson, PLLC - Morgantown; Wilmer Cutler Pickering Hale & Dorr LLP; Wilson Sonsini Goodrich & Rosati | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Takeda GMBH v. Mylan Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is Start Trial .
Details for Takeda GMBH v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-10-05 | 24 | Plaintiffs’ U.S. Patent Nos. 5,712,298 (the “’298 patent”), 8,536,206 (the “’206 patent”), 8,604,064 (the…(the “’064 patent”), 8,618,142 (the “’142 patent”). Plaintiffs sell roflumilast tablets under the tradename…claims of the ’298, ’206, ’064, and ’142 patents, and that the patents are invalid. Additionally, Mylan has…Page 3 of 12 PageID #: 281 U.S. Patent No. 8,431,154 (the “’154 patent”), which, at present, has not been… ’206, ’064,’142, and ’154 patents are referred to herein as the “patents-in-suit.” | External link to document | |
| 2015-10-09 | 26 | #39;298 patent," as used herein, refers to and includes United States Patent No. 5,712,298, titled…combination of, or all of United States Patent Nos. 5,712,298, 8,431, 154, 8,536,206, 8,604,064, and …matter of the patents-in-suit or any patents or patent applications related to the patents-in-suit, and… The phrase "patents or patent applications related to the patents-in-suit" means every…enforcement or defense of any patent-in-suit or any related patent or patent application, and identification | External link to document | |
| 2015-11-12 | 40 | U.S. Patent No. 5,712,298 to reflect a patent term extension granted by the United States Patent and … Date of Expiration of Patents: • U.S. Patent No. 5,712,298: January 27, 2020 … Amended Supplemental Information for Patent Cases Involving An Abbreviated New Drug Application… AMENDED SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG…hereby amend their “Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application | External link to document | |
| 2015-11-23 | 45 | of the patents-in-suit for deposition is as follows: • U.S. Patent No. 5.712«298; The sole… this patent, Dr. Hermann Amschler, is deceased. • U.S. Patent Nos. … • U.S. Patent No. 8.431.154; There are three named inventors on this patent, …three named inventors on these patents, all of whom reside in Germany: Mr. … 27 May 2015 1:15-cv-00093 830 Patent None District Court, N.D. West | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
